Mark Shearman - EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Evp, Chief Scientific Officer
Stock Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Shearman since 12/22/2023

Holdings reported by Mark Shearman for Editas Medicine, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 65.6K $714K $10.90 Feb 13, 2023 Direct

Transactions reported by Mark Shearman for Editas Medicine, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.